Lunivia® (eszopiclone)
Lunivia is indicated for the treatment of insomnia, in adults, usually for short-term duration.
Benzodiazepines or benzodiazepine-like substances are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.
Lunivia is licensed for use for up to 6 months, in certain situations such as chronic insomnia, with regular monitoring.
Information on Lunivia is now available in the British National Formulary and MIMS.
The NHS list price for Lunivia is £3.99 for 30 tablets for the 1 mg, 2 mg or 3 mg dose.
For further information on Lunivia, please contact axunio
Summary of Product Characteristics
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to [email protected]
LUN012504a2 October 2025
